Works matching DE "DRUG side effects"
Results: 5000
SGLT2 inhibitors: Exploring the effects in humans and horses.
- Published in:
- Equine Veterinary Education, 2025, v. 37, n. 4, p. 216, doi. 10.1111/eve.14071
- By:
- Publication type:
- Article
Horse owner experiences and observations with the use of SGLT2i for the management of equine metabolic syndrome and hyperinsulinaemia‐associated laminitis.
- Published in:
- Equine Veterinary Education, 2025, v. 37, n. 4, p. 202, doi. 10.1111/eve.13975
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Lubiprostone and Osmotic Laxatives in Chronic Idiopathic Constipation: A Systematic Review and Network Meta‐Analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 2, p. 387, doi. 10.1111/jgh.16844
- By:
- Publication type:
- Article
Comparative Success Rate and Adverse Effects of Endoscopic Sphincterotomy Versus Endoscopic Papillary Large Balloon Dilation in Large Common Bile Duct Stones Removal. A Propensity Scores Inverse Weighting Analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 2, p. 510, doi. 10.1111/jgh.16825
- By:
- Publication type:
- Article
First‐In‐Human Safety, Tolerability, and Pharmacokinetics of PPI‐1011, a Synthetic Plasmalogen Precursor.
- Published in:
- CTS: Clinical & Translational Science, 2025, v. 18, n. 3, p. 1, doi. 10.1111/cts.70195
- By:
- Publication type:
- Article
Cystectomy and lymphadenectomy – we now node how far to go!
- Published in:
- BJU International, 2025, v. 135, n. 3, p. 425, doi. 10.1111/bju.16599
- By:
- Publication type:
- Article
Real‐life experience with disease‐modifying drugs in hereditary transthyretin amyloid polyneuropathy: A clinical and electrophysiological appraisal.
- Published in:
- European Journal of Neurology, 2025, v. 32, n. 1, p. 1, doi. 10.1111/ene.16571
- By:
- Publication type:
- Article
Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis.
- Published in:
- European Journal of Neurology, 2025, v. 32, n. 1, p. 1, doi. 10.1111/ene.16463
- By:
- Publication type:
- Article
Evaluating the Efficacy of Capreomycin and Levofloxacin Combination Therapy in Multidrug‐Resistant Tuberculosis Patients.
- Published in:
- APMIS, 2025, v. 133, n. 3, p. 1, doi. 10.1111/apm.70004
- By:
- Publication type:
- Article
Caffeine-induced fixed drug eruption: evidence from a positive patch test.
- Published in:
- British Journal of Dermatology, 2025, v. 192, n. 4, p. 775, doi. 10.1093/bjd/ljae463
- By:
- Publication type:
- Article
Research Letter: Patient Attitudes Towards Haemophilia Gene Therapy at a US Haemophilia Treatment Center.
- Published in:
- Haemophilia, 2025, v. 31, n. 1, p. 166, doi. 10.1111/hae.15139
- By:
- Publication type:
- Article
Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant and sumatriptan: A phase 1, randomized, placebo‐controlled study in healthy adults.
- Published in:
- Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 2, p. 315, doi. 10.1111/head.14853
- By:
- Publication type:
- Article
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 1, p. 24, doi. 10.1111/head.14827
- By:
- Publication type:
- Article
Reactogenicity of hexavalent vaccines modelled in Swedish birth cohorts.
- Published in:
- Acta Paediatrica, 2025, v. 114, n. 2, p. 440, doi. 10.1111/apa.17469
- By:
- Publication type:
- Article
Dermatologic immune‐related adverse events: It is time for a game change!
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 3, p. e271, doi. 10.1111/jdv.20282
- By:
- Publication type:
- Article
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice Experiment: Value of Innovative Multiple Myeloma Treatments: S. Syeed et al.
- Published in:
- PharmacoEconomics, 2025, v. 43, n. 4, p. 403, doi. 10.1007/s40273-024-01459-8
- By:
- Publication type:
- Article
Enriched class II HLA inherence in patients with checkpoint inhibitor‐associated bullous pemphigoid.
- Published in:
- International Journal of Dermatology, 2025, v. 64, n. 2, p. 399, doi. 10.1111/ijd.17563
- By:
- Publication type:
- Article
Acute generalized exanthematous pustulosis and generalized pustular psoriasis: not so different differentials?
- Published in:
- International Journal of Dermatology, 2025, v. 64, n. 2, p. 419, doi. 10.1111/ijd.17388
- By:
- Publication type:
- Article
Pharmacotherapy for patients with calcium oxalate stones and abnormal urine chemistry: A systematic review and meta‐analysis for the Japanese Clinical Practice Guidelines for the Management of Urinary Stones, Third Edition.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 1, p. 16, doi. 10.1111/iju.15608
- By:
- Publication type:
- Article
Comparing the performance of multiple trigger tools in identifying medication‐related hospital readmissions.
- Published in:
- Journal of the American Geriatrics Society, 2025, v. 73, n. 1, p. 162, doi. 10.1111/jgs.19216
- By:
- Publication type:
- Article
Association of nursing home antipsychotic reduction policies with antipsychotic use in community dwellers with dementia.
- Published in:
- Journal of the American Geriatrics Society, 2025, v. 73, n. 1, p. 214, doi. 10.1111/jgs.19184
- By:
- Publication type:
- Article
Variations in Octreotide Dosing in Published Reports of Sulfonylurea Toxicity: A Systematic Review, 1988-Present.
- Published in:
- Journal of Medical Toxicology, 2025, v. 21, n. 2, p. 260, doi. 10.1007/s13181-024-01054-5
- By:
- Publication type:
- Article
Development and Content Analysis Protocol for Evaluating Artificial Intelligence in Drug‐Related Information.
- Published in:
- Journal of Evaluation in Clinical Practice, 2025, v. 31, n. 1, p. 1, doi. 10.1111/jep.14276
- By:
- Publication type:
- Article
Strategies employed and experiences associated with the implementation of pharmaceutical services and interventions in geriatric wards: A scoping review.
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 3, p. 729, doi. 10.1111/bcp.16373
- By:
- Publication type:
- Article
Fixed dosing of alpelisib for children with vascular anomalies: Can we do better?
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 3, p. 914, doi. 10.1111/bcp.16388
- By:
- Publication type:
- Article
Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 3, p. 799, doi. 10.1111/bcp.16318
- By:
- Publication type:
- Article
β‐Blockers and risk of neuropsychiatric disorders: A systematic review and meta‐analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 2, p. 325, doi. 10.1111/bcp.16361
- By:
- Publication type:
- Article
Economic burden of hospital admissions for adverse drug reactions in France: The IATROSTAT‐ECO study.
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 2, p. 439, doi. 10.1111/bcp.16266
- By:
- Publication type:
- Article
Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 2, p. 270, doi. 10.1111/bcp.15956
- By:
- Publication type:
- Article
A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 12, p. 1127, doi. 10.1080/17512433.2024.2429677
- By:
- Publication type:
- Article
Clozapine for persons with neurodevelopmental disorders: a systematic review and expert recommendations for clinical practice.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 10, p. 923, doi. 10.1080/17512433.2024.2410395
- By:
- Publication type:
- Article
The outcomes of goal-oriented medication reviews for the elderly: current research and future directions.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 9, p. 767, doi. 10.1080/17512433.2024.2400248
- By:
- Publication type:
- Article
Drug related adverse event assessment in neonates in clinical trials and clinical care.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 9, p. 803, doi. 10.1080/17512433.2024.2390927
- By:
- Publication type:
- Article
Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 5/6, p. 505, doi. 10.1080/17512433.2024.2354276
- By:
- Publication type:
- Article
Engaging patients in conversations about deprescribing.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 5/6, p. 419, doi. 10.1080/17512433.2024.2343913
- By:
- Publication type:
- Article
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 5/6, p. 441, doi. 10.1080/17512433.2024.2343875
- By:
- Publication type:
- Article
Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 3, p. 255, doi. 10.1080/17512433.2024.2311875
- By:
- Publication type:
- Article
Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 2, p. 189, doi. 10.1080/17512433.2024.2306223
- By:
- Publication type:
- Article
Adverse clinical outcomes associated with drug-related hospitalizations in people with dementia.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 1, p. 73, doi. 10.1080/17512433.2023.2294007
- By:
- Publication type:
- Article
Dasatinib‐induced haemorrhagic colitis in a child with acute lymphoblastic leukaemia.
- Published in:
- Journal of Paediatrics & Child Health, 2025, v. 61, n. 2, p. 284, doi. 10.1111/jpc.16749
- By:
- Publication type:
- Article
Ifosfamide-induced nephrotoxicity in oncological patients.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 1/2, p. 5, doi. 10.1080/14737140.2023.2290196
- By:
- Publication type:
- Article
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer.
- Published in:
- CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 2, p. 87, doi. 10.3322/caac.70003
- By:
- Publication type:
- Article
Serious adverse effects of selected antiseizure medications used for treatment of focal onset seizures.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 2, p. 129, doi. 10.1080/14740338.2024.2446416
- By:
- Publication type:
- Article
Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 2, p. 233, doi. 10.1080/14740338.2024.2355336
- By:
- Publication type:
- Article
Safety concerns of aztreonam: a real-world disproportionality analysis based on FDA Adverse Event Reporting System.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 3, p. 325, doi. 10.1080/14740338.2024.2430307
- By:
- Publication type:
- Article
Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 3, p. 315, doi. 10.1080/14740338.2024.2424443
- By:
- Publication type:
- Article
Real-world safety evaluation of atorvastatin: insights from the US FDA adverse event reporting system (FAERS).
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 3, p. 305, doi. 10.1080/14740338.2024.2424438
- By:
- Publication type:
- Article
Comprehensive evaluation of leuprorelin-associated adverse events: insights from FDA adverse event reporting system.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 3, p. 355, doi. 10.1080/14740338.2024.2423680
- By:
- Publication type:
- Article
Signal detection of adverse reactions for bendamustine based on FDA adverse event reporting system.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 2, p. 221, doi. 10.1080/14740338.2024.2348573
- By:
- Publication type:
- Article
Congenital anomalies associated with the use of cardiovascular drugs during pregnancy: a large-scale data analysis from the FAERS database.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 2, p. 193, doi. 10.1080/14740338.2024.2442519
- By:
- Publication type:
- Article